Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 3061 AL 3075

Hyperglycemic Nonketotic Signal Changes of the Striatum: An Unusual Complication in the Setting of Neurosurgical Procedures

Abou-Al-Shaar H, Alzhrani G, Gozal YM, Karsy M, Couldwell WT.

World Neurosurg. 2018 Oct;118:177-180. doi: 10.1016/j.wneu.2018.07.008. Epub 2018 Jul 11.

The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease

Blum D, Chern Y, Domenici MR, Buée L, Lin CY, Rea W, Ferré S, Popoli P.

J Caffeine Adenosine Res. 2018 Jun 1;8(2):43-58. doi: 10.1089/caff.2018.0006.

Huntington's disease: the coming of age

Pandey M, Rajamma U.

J Genet. 2018 Jul;97(3):649-664.

Human cellular models of medium spiny neuron development and Huntington disease

Golas MM.

Life Sci. 2018 Sep 15;209:179-196. doi: 10.1016/j.lfs.2018.07.030. Epub 2018 Jul 18.

Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences

Rangel-Barajas C, Rebec GV.

Curr Protoc Neurosci. 2018 Apr;83(1):e47. doi: 10.1002/cpns.47.

Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders

Anderson KE, van Duijn E, Craufurd D, Drazinic C, Edmondson M, Goodman N, van Kammen D, Loy C, Priller J, Goodman LV.

J Huntingtons Dis. 2018;7(3):355-366. doi: 10.3233/JHD-180293.

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR.

Front Neurosci. 2018 Jul 10;12:466. doi: 10.3389/fnins.2018.00466. eCollection 2018.

Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders

Enogieru AB, Haylett W, Hiss DC, Bardien S, Ekpo OE.

Oxid Med Cell Longev. 2018 Jun 27;2018:6241017. doi: 10.1155/2018/6241017. eCollection 2018.

Emerging strategies targeting CB(2) cannabinoid receptor: Biased agonism and allosterism

Morales P, Goya P, Jagerovic N.

Biochem Pharmacol. 2018 Nov;157:8-17. doi: 10.1016/j.bcp.2018.07.031. Epub 2018 Jul 26.

Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease

Wesson M, Boileau NR, Perlmutter JS, Paulsen JS, Barton SK, McCormack MK, Carlozzi NE.

J Huntingtons Dis. 2018;7(3):239-249. doi: 10.3233/JHD-180299.

Effects of multidisciplinary therapy on physical function in Huntington's disease

Cruickshank TM, Reyes AP, Penailillo LE, Pulverenti T, Bartlett DM, Zaenker P, Blazevich AJ, Newton RU, Thompson JA, Lo J, Ziman MR.

Acta Neurol Scand. 2018 Dec;138(6):500-507. doi: 10.1111/ane.13002. Epub 2018 Jul 30.

System biology approach intersecting diet and cell metabolism with pathogenesis of brain disorders

Gomez-Pinilla F, Yang X.

Prog Neurobiol. 2018 Oct;169:76-90. doi: 10.1016/j.pneurobio.2018.07.001. Epub 2018 Jul 27.

Functions and dysfunctions of the mammalian centrosome in health, disorders, disease, and aging

Schatten H, Sun QY.

Histochem Cell Biol. 2018 Oct;150(4):303-325. doi: 10.1007/s00418-018-1698-1. Epub 2018 Jul 30.

In vivo characterization of white matter pathology in premanifest huntington's disease

Zhang J, Gregory S, Scahill RI, Durr A, Thomas DL, Lehericy S, Rees G, Tabrizi SJ, Zhang H; TrackOn-HD investigators.

Ann Neurol. 2018 Oct;84(4):497-504. doi: 10.1002/ana.25309. Epub 2018 Sep 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias